Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Ind-Swift Laboratories Limited

Market Cap 1.14TCr 12Cr 10Cr 9.52Cr 8.92Cr 17Cr 17Cr 113.57Cr 44Cr 549.35Cr 45Cr 44Cr 1.91TCr P/E Ratio 2024
1.41x
P/E Ratio 2025 2.38x
Enterprise Value 713.1Cr 7.45Cr 6.46Cr 5.96Cr 5.58Cr 10Cr 11Cr 71Cr 28Cr 343.74Cr 28Cr 27Cr 1.2TCr EV / Sales 2024
0.14x
EV / Sales 2025 0.12x
Free-Float
40.56%
Yield 2024 *
-
Yield 2025 -
1 day+2.42%
1 week+2.83%
Current month+6.81%
1 month+17.94%
3 months+13.24%
6 months+65.94%
Current year+84.31%
1 week 154.2
Extreme 154.2
169.9
1 month 129.31
Extreme 129.31
173.25
Current year 87.25
Extreme 87.25
173.25
1 year 87.15
Extreme 87.15
173.25
3 years 68.72
Extreme 68.72
186
5 years 52.65
Extreme 52.65
186
10 years 15
Extreme 15
186
Manager TitleAgeSince
Chief Executive Officer 74 04/01/1995
Chief Executive Officer 43 15/06/2011
Director of Finance/CFO - 29/09/2018
Director TitleAgeSince
Director/Board Member 43 -
Chairman 74 -
Director/Board Member 35 23/03/2010
Date Insider Type Main position Quantity % Market Cap.
12/24/12Sell

Chief Financial Officer

30,000 0.0508%
Change 5-day change 1-year change 3-year change Capi.($)
+2.07%+2.83%+47.35%+132.93% 15Cr
+0.23%+0.83%+6.50%+82.35% 4.5TCr
-0.64%-4.02%+37.40%+86.43% 3.37TCr
+0.35%-0.85%-7.55%+44.74% 1.17TCr
+0.61%+2.22%+13.73%+118.27% 1.16TCr
0.00%+0.39%+36.53%+125.55% 894.45Cr
-1.44%-1.94%+15.12%+39.35% 700.72Cr
-1.90%-1.51%+38.79%-19.37% 651.35Cr
+0.16%-0.82%+31.04%+236.47% 635.21Cr
-0.45%-2.96%-39.97%-6.82% 514.7Cr
Average -0.07%-0.47%+17.89%+83.99% 1.36TCr
Weighted average by Cap. -0.19%-1.81%+16.96%+82.83%

Financials

2024 2025
Net sales 1.3TCr 14Cr 12Cr 11Cr 10Cr 19Cr 19Cr 129.28Cr 50Cr 625.32Cr 51Cr 50Cr 2.17TCr 561.71Cr 5.87Cr 5.09Cr 4.69Cr 4.4Cr 8.22Cr 8.39Cr 56Cr 22Cr 270.76Cr 22Cr 22Cr 941.45Cr
Net income 420.96Cr 4.4Cr 3.82Cr 3.52Cr 3.3Cr 6.16Cr 6.29Cr 42Cr 16Cr 202.92Cr 17Cr 16Cr 705.55Cr 250.48Cr 2.62Cr 2.27Cr 2.09Cr 1.96Cr 3.66Cr 3.74Cr 25Cr 9.66Cr 120.74Cr 9.82Cr 9.61Cr 419.81Cr
Net Debt -415.31Cr -4.34Cr -3.76Cr -3.47Cr -3.25Cr -6.07Cr -6.2Cr -41Cr -16Cr -200.19Cr -16Cr -16Cr -696.07Cr -426.55Cr -4.45Cr -3.87Cr -3.56Cr -3.34Cr -6.24Cr -6.37Cr -43Cr -16Cr -205.61Cr -17Cr -16Cr -714.91Cr
Logo Ind-Swift Laboratories Limited
Ind-Swift Laboratories Limited is an India-based company, which is engaged in the business of manufacturing active pharmaceutical ingredients (APIs), intermediates and formulations. The Company operates in the Pharmaceutical Business segment. It also focuses on manufacturing formulations. The Company’s products include APIs and Impurities. Its APIs therapeutic category includes Macrolide Antibiotic, Cardiovascular, Antihistaminic, Antidiabetic, Antipsyhotic, Bone Resorption Inhibitor, and Aromatase Inhibitor. Its products include Clarithromycin, Clarithromycin Coated Granules, Clarithromycin Citrate, Atorvastatin Calcium Crystalline, Atorvastatin Calcium Amorphous, Clopidogrel HCl, Ezetimibe, Ivabradine Oxalate, Ranolazine, Aripiprazole, Risedronate Sodium, Ropinirole HCl, Cinacalcet HCl, Letrozole, and Anastrozole. Its products under development include Sitagliptin Phosphate, Mirabegron, Bempedoic Acid, Lasmiditan, and Eltrombopag Olamine.
Employees
1,246
Date Price Change Volume
12/26/12 161.92 +2.07% 46,589
11/26/11 158.63 -2.60% 5,66,933
10/26/10 162.86 +0.61% 13,51,221
09/26/09 161.87 +3.27% 17,00,677
08/26/08 156.74 -0.80% 8,48,615
  1. Stock Market
  2. Stocks
  3. INDSWFTLAB Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!